EUVIMEDEUVIMED entdecken
Crossref

Analysis of a novel high-power low-temperature plasma indicates treatment of psoriasis through inhibition of the NF-κB pathway and Th17/IL-23 cell axis

Changcheng Yang, Xiujuan Li, Juan Li, Jiahe Li, Yi Li, Jinhua Yang, Xuedong Wang, Peng Guo, Yupeng Wang, Aiguo Wang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Changcheng Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian 116044, Liaoning, China. Hauptthemen laut MEDLINE: Psoriasis, Th17 Cells, NF-kappa B, Plasma Gases. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to evaluate the therapeutic efficacy and potential underlying mechanisms of a novel high-power low-temperature plasma (hLTP) therapy for treatment of psoriasis. Imiquimod (IMQ)-induced rat psoriasis model was used to evaluate the therapeutic efficacy of hLTP. Potential mechanisms were explored using bioinformatics analysis and molecular biology validation based on transcriptomic data. hLTP treatment alleviated IMQ-induced psoriasis as evidenced by a significantly reduced psoriasis area and severity index scores (PASI), and pathological changes. Based on the transcriptomic data, the differential expressed genes (DEGs) positively or negatively related to the hLTP treatment was identified and bioinformatics analysis was further performed. The results of the verification experiment indicate that hLTP treatment significantly elevated nitric oxide (NO) levels and FKBP5 expression in psoriasis, which was associated with inhibition of the NF-κBpathway, as indicated by reduced p-IKK/IKK and p-P65/P65 ratios. Apoptosis was suppressed, evidenced by a decreased cleaved-caspase3/caspase3 ratio and lower self-DNA levels. Antioxidant capacity was enhanced, shown by increased glutathione (GSH) levels, while the inflammatory response was mitigated with reduced cathelicidin (LL-37) levels. These effects resulted in reduced psoriasis-related pro-inflammatory cytokines (IL-23, IL-6, and TGF-β) from dendritic cells and macrophages, preventing Th17 cell differentiation and suppressing it related cytokines (IL-17 A, IL-22, IL-17F, TNF-α). Consequently, the Th17/IL-23 cell axis was disrupted under hLTP treatment.This is a novel study that provides conclusive data demonstrating that hLTP exerts significant therapeutic effects on psoriasis through its anti-inflammatory, antioxidant, and anti-apoptotic effects by significantly up-regulating NO and FKBP5, while inhibiting NF-κB pathway and Th17/IL-23 cell axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisTh17 CellsNF-kappa BPlasma GasesAnimalsMaleRatsSignal TransductionInterleukin-23ImiquimodDisease Models, AnimalRats, Sprague-DawleyHumansApoptosisNitric OxideSkinTacrolimus Binding ProteinsTacrolimus Binding Protein 5

Stichwörter der Autor:innen

High-powerLow-temperature plasma (LTP)NOPsoriasisTh17/IL-23 cell axis

Substanzen

NF-kappa BPlasma GasesInterleukin-23ImiquimodNitric OxideTacrolimus Binding ProteinsTacrolimus Binding Protein 5

Autor:innen und Institutionen

  • Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian 116044, Liaoning, China.
  • Yantai Healing Technology Co. Ltd., Yantai 264006, Shandong, China.
  • Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China. Electronic address: rmyyguopeng@163.com.
  • Yantai Healing Technology Co. Ltd., Yantai 264006, Shandong, China. Electronic address: 13901237491@139.com.
  • Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian 116044, Liaoning, China. Electronic address: wangaiguo@dmu.edu.cn.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Yang, C., Li, X., Li, J., Li, J., Li, Y., Yang, J., Wang, X., Guo, P., Wang, Y., & Wang, A. (2025). Analysis of a novel high-power low-temperature plasma indicates treatment of psoriasis through inhibition of the NF-κB pathway and Th17/IL-23 cell axis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115239

Vancouver

Yang C, Li X, Li J, Li J, Li Y, Yang J, et al. Analysis of a novel high-power low-temperature plasma indicates treatment of psoriasis through inhibition of the NF-κB pathway and Th17/IL-23 cell axis. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115239

BibTeX
@article{Yang2025,
  author = {Yang, Changcheng and Li, Xiujuan and Li, Juan and Li, Jiahe and Li, Yi and Yang, Jinhua and Wang, Xuedong and Guo, Peng and Wang, Yupeng and Wang, Aiguo},
  title = {Analysis of a novel high-power low-temperature plasma indicates treatment of psoriasis through inhibition of the NF-κB pathway and Th17/IL-23 cell axis},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115239}
}
Kostenlos starten →